Labcorp Holdings Inc.
LHNYSEHealthcareDiagnostics & Research

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governments, physician, large provider organizations, other healthcare providers, hospitals and health systems, patients and consumers, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 and is headquartered in Burlington, North Carolina.

Stock Details

ExchangeNYSE (NYSE)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone336-584-5171
Address
531 South Spring Street Burlington, North Carolina 27215 United States

Corporate Identifiers

CIK0000920148
CUSIP504922105
ISINUS5049221055
EIN99-2588107
SIC8071

Leadership Team & Key Executives

Adam H. Schechter
President, Chief Executive Officer and Chairman
Julia A. Wang
Chief Financial Officer and Executive Vice President
Mark S. Schroeder
Executive Vice President, President of Diagnostics Laboratories and Chief Operating Officer
Dr. Brian J. Caveney J.D., M.D., M.P.H.
EVice President, President of Early Development Research Laboratories and Chief Medical and Scientific Officer
Anita Z. Graham
Executive Vice President and Chief Human Resources Officer
Peter J. Wilkinson
Senior Vice President and Chief Accounting Officer
Akinbolade Oyegunwa M.B.A., Ph.D.
Executive Vice President and Chief Information and Technology Officer
Christin O'Donnell
Vice President of Investor Relations
Sandra D. van der Vaart J.D.
Executive Vice President, Chief Legal Officer and Corporate Secretary
Amy B. Summy
EVice President, Chief Marketing Officer and Consumer Business Lead